Palynziq Injection, Solution
Product Images NDC 68135-756

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Palynziq (NDC 68135-756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomarin Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Palynziq 1)

A line graph depicting mean observed blood phenylalanine levels (in micromol/L) over four time points: Pre-treatment Baseline, Study 302 Randomized Withdrawal Baseline, Week 4, and Week 8. Four groups are shown: Palynziq 20 mg once daily, Placebo 20 mg once daily, Palynziq 40 mg once daily, and Placebo 40 mg once daily, each with error bars representing variability. The graph compares changes in phenylalanine levels among these treatment groups during the study.*

FDA Label Image

Figure I (Palynziq 10)

An instructional diagram showing recommended subcutaneous injection sites for Palynziq (pegvaliase-pqpz). Highlighted areas suitable for injection include the abdomen, front and back of the thighs, back of the arms, and buttocks. The front and back views of a human figure are displayed with these injection zones clearly marked.*

FDA Label Image

Figure J (Palynziq 11)

An instructional diagram showing a close-up view of a curved surface with two holes spaced 2 inches apart, likely indicating a measurement or spacing guideline between two points.*

FDA Label Image

Figure K (Palynziq 12)

An illustration showing hands being rinsed under running water from a faucet, demonstrating proper handwashing technique.*

FDA Label Image

Figure L (Palynziq 13)

Illustration showing a hand wiping a marked area on skin with a cloth or wipe, likely demonstrating a step for preparing a subcutaneous injection site for Palynziq (pegvaliase-pqpz) injection, solution.*

FDA Label Image

Figure M (Palynziq 14)

An illustration showing a hand holding a syringe injecting medication subcutaneously into the skin. The syringe contains a clear solution, and the needle is inserted at an angle under the skin, demonstrating proper subcutaneous injection technique.*

FDA Label Image

Figure N (Palynziq 15)

An instructional illustration depicting the preparation for a subcutaneous injection. One hand is holding an injection syringe near the skin, and the other hand is removing a cap from the syringe needle, indicated by an upward pointing arrow.*

FDA Label Image

Figure O (Palynziq 16)

An instructional illustration showing the technique for subcutaneous injection, specifically demonstrating pinching the skin to prepare for injection with a syringe. The image focuses on hand positioning and proper skin pinching prior to administering the injection.*

FDA Label Image

Figure P (Palynziq 17)

An instructional diagram demonstrating subcutaneous injection technique for Palynziq (pegvaliase-pqpz). The first panel shows inserting the needle at a 90-degree angle, then adjusting to a 45-degree angle. The second panel illustrates moving the hand into the injection position, holding the syringe steadily during administration.*

FDA Label Image

Figure Q (Palynziq 18)

An instructional illustration showing a hand holding a Palynziq prefilled syringe for subcutaneous injection. A close-up detail highlights the needle cap removal process before administration of the pegvaliase-pqpz injection solution by BioMarin Pharmaceutical Inc.*

FDA Label Image

Figure R (Palynziq 19)

An instructional illustration showing a hand holding a syringe with a needle cap. An arrow indicates pulling the needle cap upwards to remove it from the syringe, demonstrating preparation for injection.*

FDA Label Image

Figure A (Palynziq 2)

Illustration showing components related to Palynziq injection, including a prefilled syringe in sealed tray with labeling, a gauze pad or cotton ball, an alcohol pad, a bandage, and a sharps disposal container. The image visually represents materials needed for subcutaneous administration and disposal of Palynziq (pegvaliase-pqpz) injection.*

FDA Label Image

Figure S (Palynziq 20)

An instructional illustration showing a hand disposing of a used syringe into a red sharps disposal container. This image relates to the safe disposal of injection materials for the subcutaneous injection product Palynziq (pegvaliase-pqpz).*

FDA Label Image

Figure T (Palynziq 21)

An instructional illustration showing a hand holding a box labeled Palynziq (pegvaliase-pqpz) with instructions to dispense the enclosed Medication Guide to each patient. An arrow points from the box toward an open refrigerator, indicating the medication should be stored in the refrigerator.*

FDA Label Image

2.5 mg Carton (Palynziq 22)

Carton label for Palynziq (pegvaliase-pqpz) Injection 2.5 mg/0.5 mL, a subcutaneous injection solution by BioMarin Pharmaceutical Inc. The label states storage instructions, dosage form, and single-dose prefilled syringe packaging. It includes caution to dispense the Medication Guide, and notes the syringe contains 2.5 mg in 0.5 mL with inactive ingredients listed.*

FDA Label Image

2.5 mg Tray Cover (Palynziq 23)

Label for Palynziq injection, pegvaliase-pqpz, 2.5 mg/0.5 mL strength in a single-dose prefilled syringe. The injectable solution is for subcutaneous use only. The label includes storage instructions to refrigerate at 36°F to 46°F and warnings against freezing or shaking. Manufactured by BioMarin Pharmaceutical Inc., located in Novato, CA.*

FDA Label Image

2.5 mg Syringe Label (Palynziq 24)

Palynziq 2.5 mg/0.5 mL injection solution label showing the proprietary and generic names pegvaliase-pqpz. Label includes the BioMarin Pharmaceutical Inc. name, US license number 1649, and batch information. The label is primarily white with black text and a small barcode.*

FDA Label Image

10 mg Carton (Palynziq 25)

Palynziq 10 mg/0.5 mL injection solution label for subcutaneous use by BioMarin Pharmaceutical Inc. The label indicates a single-dose prefilled syringe per tray and storage instructions to refrigerate between 36°F to 46°F (2°C to 8°C). It includes dosage information, inactive ingredients, and emphasizes dispensing the medication guide with each patient.*

FDA Label Image

10 mg Tray Cover (Palynziq 26)

Label for Palynziq (pegvaliase-pqpz) injection, 10 mg/0.5 mL strength in a single-dose prefilled syringe. The label states it is for subcutaneous use only and includes storage instructions to refrigerate at 36°F to 46°F (2°C to 8°C) in the original carton, avoiding freezing or shaking. Manufactured by BioMarin Pharmaceutical Inc.*

FDA Label Image

10 mg Syringe Label (Palynziq 27)

Label for Palynziq (pegvaliase-pqpz) injection, solution, subcutaneous, strength 10 mg/0.5 mL. The label displays the product name, dosage strength in a green box, and is labeled by BioMarin Pharmaceutical Inc.*

FDA Label Image

20 mg Carton (Palynziq 28)

Packaging label for Palynziq (pegvaliase-pqpz) injection, solution, 20 mg/mL for subcutaneous use. The carton contains a single-dose prefilled syringe. Label includes storage instructions, dosage form, and manufacturer BioMarin Pharmaceutical Inc.*

FDA Label Image

20 mg Tray Cover (Palynziq 29)

Label for Palynziq (pegvaliase-pqpz) Injection 20 mg/mL, a subcutaneous injection solution. The label indicates it is for prescription use only, in a single-dose prefilled syringe. Instructions include refrigerating between 36°F to 46°F and protecting from light. Manufactured by BioMarin Pharmaceutical Inc.*

FDA Label Image

Figure B (Palynziq 3)

An instructional diagram illustrating the parts of a Palynziq (pegvaliase-pqpz) injection syringe. Labeled components include the needle cap, needle, syringe body, syringe label, viewing window, finger grips, plunger, and plunger head. The syringe label on the body shows the product name.*

FDA Label Image

20 mg Syringe Label (Palynziq 30)

Palynziq (pegvaliase-pqpz) injection, solution label showing strength 20 mg/mL. The label includes the BioMarin Pharmaceutical Inc. name and US License No. 1649 with a lot number and other small printed codes.*

FDA Label Image

20 mg Carton (multi Pack) (Palynziq 31)

Packaging label for Palynziq (pegvaliase-pqpz) injection, 20 mg/mL strength, a subcutaneous injection solution. The carton contains ten 20 mg/mL single-dose prefilled syringes. Labeler is BioMarin Pharmaceutical Inc. Storage instructions advise refrigeration at 36°F to 46°F (2°C to 8°C) and protection from light. The label includes dosing reminders and notes no preservatives are present.*

FDA Label Image

Figure C (Palynziq 4)

Palynziq (pegvaliase-pqpz) injection packaging and prefilled syringes shown in three strengths for subcutaneous use: 2.5 mg/0.5 mL in white label and syringe, 10 mg/0.5 mL in green label and syringe, and 20 mg/mL in blue label and syringe. Each package displays dosage strength, usage instructions, and labeler BioMarin Pharmaceutical Inc.*

FDA Label Image

Figure D (Palynziq 5)

An instructional illustration showing the location of the expiration date on a product carton. The image highlights the expiration date format (EXP MM/YYYY) on the side panel of the box, with a focus on how it should be viewed.*

FDA Label Image

Figure E (Palynziq 6)

An instructional illustration showing hands holding a Palynziq injection device labeled with pegvaliase-pqpz. The label shows placeholder strength XX mg/XX mL and indicates subcutaneous use only. The image includes a caution to dispense the enclosed Medication Guide to each patient.*

FDA Label Image

Figure F (Palynziq 7)

Palynziq (pegvaliase-pqpz) injection solution packaging label showing partial NDC code and storage instructions. Label indicates refrigeration at 366F to 468F (26C to 86C) in the original container, with warnings against freezing and shaking. Manufacturer identified as BioMarin Pharmaceutical Inc., Novato, CA. The label also references usage of a prefilled syringe in available dosages.*

FDA Label Image

Figure G (Palynziq 8)

An instructional illustration showing hands holding a prefilled syringe with a needle cap, likely demonstrating how to hold the syringe securely prior to subcutaneous injection. The syringe appears to be part of the Palynziq (pegvaliase-pqpz) injection supply.*

FDA Label Image

Figure H (Palynziq 9)

An instructional illustration showing a hand holding a syringe filled with a solution. The syringe is depicted in a cross-sectional view, revealing its internal components including the plunger and needle. The hand is positioned to push the plunger, indicating preparation for injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.